摘要
多发性硬化（MS）是主要以中枢神经系统（CNs）白质脱髓鞘病变为主要特点的自身免疫性疾病，探索有价值的生物标记已成为目前研究MS的一个重要热点。生物标记有助于MS的早期诊断和鉴别诊断，指导治疗方案，推断MS疾病活动性，以及判断疗效。生物标记最好符合以下要求：
出处
《中国神经免疫学和神经病学杂志》
CAS
2011年第4期237-240,共4页
Chinese Journal of Neuroimmunology and Neurology
参考文献4
-
1Villoslada P. Biomarkers for multiple selerosis[J]. Drug News Perspect, 2010,23:585 595.
-
2Graber J J, Dhib-Jalbut S. Biomarkers of disease activity inmultiple sclerosis[J]. J Neurol Sci, 2011,305 : 1 10.
-
3Brettschneider J, Tumani H, Kiechle U, et al. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome[J]. PLoSONE, 2009, 4: e7638.
-
4Brilot F, Dale RC, Selter RC, et al. Antibodies to native my- elin oligodendrocyte glyeoprotein in children with inflammatoryemyelinating central nervous system disease[J]. Ann Neurol, 2009, 66: 833-842.
同被引文献18
-
1Banwell B. Multiple sclerosis in children [J]. Handb Clin Neu- rol, 2014, 122:427-441.
-
2Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demye- linating disorders: revisions to the 2007 definitions [J]. Muh Scler,2013,19(10) : 1261-1267.
-
3Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald crite- ria[J].Ann Neurol,2011,69(2) :292-302.
-
4Banwell B, Krupp L, Kennedy J, et al. Clinical features and vi- ral serologies in children with multiple sclerosis : a multinational observational study[J]. Lancet Neurol,2007, 6(9) : 773-781.
-
5Langer-Gould A, Qian L, Tartof SY, et al. Vaccines and the risk of multiple sclerosis and other central nervous system demy- elinating diseases[J]. JAMA Neurol, 2014, 71 (12) :1506- 1513.
-
6Reinhardt K, Weiss S, Rosenbauer J, et al. Multiple sclerosis in children and adolescents : incidence and clinical picture-new in- sights from the nationwide German surveillance (2009- 2011 ) [J]. Eur J Neurol, 2014,21 (4) : 654-659.
-
7Chou IJ, Whitehouse WP, Wang HS, et al. Diagnostic modalities in multiple sclerosis: perspectives in children [J]. Biomed J, 2014,37(2) :50-59.
-
8Heussinger N, Kontopantelis E, Rompel O, et al. Predicting mul- tiple sclerosis following isolated optic neuritis in children [J]. Eur J Neurol,2013,20(9) : 1292-1296.
-
9Kornek B. Treatment of pediatric multiple sclerosis [J]. Neuro- pediatrics, 2013,44 (6) : 309-313.
-
10Tenembaum SN, Banwell B, Pohl D, et al. Subcutaneous inter- feron Beta-la in pediatric multiple sclerosis: a retrospective study [ J ]. J Child Neurol, 2013,28 (7) : 849-856.
二级引证文献5
-
1王少卿,王苏,杨涛,仝延萍,康越之,王静文,万江龙,赵天佑,程翠翠,樊永平.51例儿童脱髓鞘病临床特点及中医证候回顾性分析[J].中华中医药杂志,2019,34(1):384-386. 被引量：1
-
2杜雅平,韩军,焦晓明,王晓暄.TNFAIP3基因多态性与变应性鼻炎遗传易感性的关联性研究[J].标记免疫分析与临床,2016,23(8):899-902. 被引量：3
-
3段广富,华青.儿童多发性硬化的治疗与随访观察[J].临床荟萃,2018,33(6):532-535.
-
4段姝洁.多发性硬化患者血清与脑脊液中IL-23、IL-17、TNF-α水平变化[J].现代仪器与医疗,2018,24(1):70-71. 被引量：3
-
5李秀娟,孙川,许蓓妮,黄胜起,陈卫光,陈建勇.白细胞介素-17A及白细胞介素-17F基因多态性与中国汉族人群强直性脊柱炎的相关性分析[J].实用医技杂志,2019,26(1):8-11. 被引量：2
-
1毕玉华,田茂.大动脉粥样硬化性脑梗死NIHSS评分与LPA水平相关性分析[J].临床医学,2014,34(9):1-2. 被引量：2
-
2刘喷飓,张星虎,刘伟,郑华光,刘云,周衡.多发性硬化患者病情演变与血浆和脑脊液基质金属蛋白酶-9水平的相关性[J].中国神经免疫学和神经病学杂志,2010,17(5):327-330. 被引量：2
-
3杨德刚,胡长林.反映多发性硬化疾病活动性的免疫学指标[J].国外医学（神经病学．神经外科学分册）,2003,30(6):539-541. 被引量：1
-
4杉杉（摘译）.拉喹莫德可降低多发性硬化患者病灶的活动性[J].中华医学信息导报,2008,23(20):22-22.
-
5YaninaGalboiz,关鸿志,等.多发性硬化活动性及预后的免疫学指标[J].世界医学杂志,2002,6(23):18-20.
-
6蒋东晓,连艳芬.分泌型磷脂酶A2、溶血磷脂酸与多发性硬化相关性研究及临床意义[J].中国医师进修杂志,2016,39(11):961-964.
-
7Acar G.,Idiman F.,Kirkali G.,赵睿.多发性硬化症鞘膜内sICAM-1产物与3倍剂量Gd-DTPA增强MRI以及IgG指数相关性的研究[J].世界核心医学期刊文摘（神经病学分册）,2005,0(8):40-40.
-
8李海峰.醋酸格拉默能够有效延缓临床孤立综合征发展成临床确诊的多发性硬化[J].中华神经科杂志,2010,43(4):305-305.
-
9郭虹,代慧宇,采江英,曹芳,付锦.多发性硬化生物标记物的研究进展[J].现代生物医学进展,2015,15(16):3183-3185. 被引量：1
-
10任晓暾,吴卫平,徐全刚,黄德晖.血清尿酸水平与多发性硬化的相关性研究[J].中国神经免疫学和神经病学杂志,2006,13(5):257-259. 被引量：3
